Soluble soy protein peptic hydrolysate stimulates adipocyte differentiation in 3T3-L1 cells

Molecular Nutrition and Food Research

Volumn 57, Issue 8, 2013, Pages 1435-1445

  Goto, Tsuyoshi ^a   Mori, Ayaka ^a   Nagaoka, Satoshi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Adipocyte differentiation; Adiponectin; Obesity; Soy peptides; Soybean protein peptic hydrolysate

Indexed keywords

GLYCINE MAX; MURINAE;

2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 2,4-THIAZOLIDINEDIONE; 2-CHLORO-5-NITROBENZANILIDE; ADIPONECTIN; ADIPOQ PROTEIN, MOUSE; ANILIDE; GLUCOSE TRANSPORTER 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN HYDROLYSATE; SLC2A4 PROTEIN, MOUSE; SOYBEAN PROTEIN;

ADIPOCYTE; ADIPOCYTE DIFFERENTIATION; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; LIPID METABOLISM; METABOLISM; MOUSE; OBESITY; SOLUBILITY; SOY PEPTIDES; SOYBEAN PROTEIN PEPTIC HYDROLYSATE;

ADIPOCYTE DIFFERENTIATION; ADIPONECTIN; OBESITY; SOY PEPTIDES; SOYBEAN PROTEIN PEPTIC HYDROLYSATE;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANILIDES; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETIC MARKERS; GLUCOSE TRANSPORTER TYPE 4; LIPID METABOLISM; MICE; PPAR GAMMA; PROTEIN HYDROLYSATES; SOLUBILITY; SOYBEAN PROTEINS; THIAZOLIDINEDIONES;

EID: 84881310706     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200573     Document Type: Article

References (59)

1. Iyer, A., Fairlie, D. P., Prins, J. B., Hammock, B. D. et al., Inflammatory lipid mediators in adipocyte function and obesity. Nat. Rev. Endocrinol. 2010, 6, 71-82.
2. Ogden, C. L., Yanovski, S. Z., Carrollm, M. D., Flegal, K. M., The epidemiology of obesity. Gastroenterology 2007, 132, 2087-2102.
3. Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371, 569-578.
4. Unger, R. H., Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 2003, 14, 398-403.
5. DeFronzo, R. A., Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53, 1270-1287.
6. Rogovik, A. L., Chanoine, J. P., Goldman, R. D., Pharmacotherapy and weight-loss supplements for treatment of paediatric obesity. Drugs 2010, 70, 335-346.
7. Stefater, M. A., Seeley, R. J., Central nervous system nutrient signaling: the regulation of energy balance and the future of dietary therapies. Annu. Rev. Nutr. 2010, 30, 219-235.
8. Cawthorn, W. P., Sethi, J. K., TNF-alpha and adipocyte biology. FEBS Lett. 2008, 582, 117-131.
9. Stern, N., Osher, E., Greenman, Y., Hypoadiponectinemia as a marker of adipocyte dysfunction-part II: the functional significance of low adiponectin secretion. J. Cardiometab. Syndr. 2007, 2, 288-294.
10. Matsuzawa, Y., The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580, 2917-2921.
11. Kadowaki, T., Hara, K., Yamauchi, T., Terauchi, Y. et al., Molecular mechanism of insulin resistance and obesity. Exp. Biol. Med. 2003, 28, 1111-1117.
12. Haslam, D. W., James, W. P., Obesity. Lancet 2005, 366, 1197-1209.
13. Sakai, T., Sakaue, H., Nakamura, T., Okada, M. et al., Skp2 controls adipocyte proliferation during the development of obesity. J. Biol. Chem. 2007, 282, 2038-2046.
14. Spiegelman, B. M., Flier, J. S., Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87, 377-389.
15. Lin, F. T., Lane, M. D., CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA 1994, 91, 8757-8761.
16. Tontonoz, P., Hu, E., Spiegelman, B. M., Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79, 1147-1156.
17. Rosen, E. D., Hsu, C. H., Wang, X., Sakai, S. et al., C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002, 16, 22-26.
18. Glass, C. K., Going nuclear in metabolic and cardiovascular disease. J. Clin. Invest. 2006, 116, 556-560.
19. Semple, R. K., Chatterjee, V. K., O'Rahilly, S., PPAR-gamma and human metabolic disease. J. Clin. Invest. 2006, 116, 581-589.
20. Lehmann, J.M., Moore, L.B., Smith-Oliver, T. A., Wilkison, W. O. et al., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 1995, 270, 12953-23956.
21. Yamauchi, T., Kamon, J., Waki, H., Murakami, K. et al., The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 2001, 276, 41245-41254.
22. Clarkson, T. B., Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 2002, 132, 566S-569S.
23. Potter, S. M., Soy protein and serum lipids. Curr. Opin. Lipidol. 1996, 7, 260-264.
24. Anderson, J. W., Johnstone, B. M., Cook-Newell, M. E., Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995, 333, 276-282.
25. Lavigne, C., Marette, A., Jacques, H., Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am. J. Physiol. Endocrinol. Metab. 2000, 278, E491-E500.
26. Ascencio, C., Torres, N., Isoard-Acosta, F., Gómez-Pérez, F. J. et al., Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J. Nutr. 2004, 134, 522-529.
27. Ronis, M. J., Chen, Y., Badeaux, J., Badger, T. M., Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J. Nutr. 2009, 139, 1431-1438.
28. Torre-Villalvazo, I., Tovar, A. R., Ramos-Barragán, V. E., Cerbón-Cervantes, M. A. et al., Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J. Nutr. 2008, 138, 462-468.
29. Nagaoka, S., Miwa, K., Eto, M., Kuzuya, Y. et al., Soy protein peptic hydrolysate with bound phospholipids decreases micellar solubility and cholesterol absorption in rats and caco-2 cells. J. Nutr. 1999, 129, 1725-1730.
30. Goto, T., Lee, J. Y., Teraminami, A., Kim, Y. I. et al., Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J. Lipid Res. 2011, 52, 873-884.
31. Goto, T., Nagai, H., Egawa, K., Kim, Y. I. et al., Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem. J. 2011, 438, 111-119.
32. Takahashi, N., Kawada, T., Goto, T., Yamamoto, T. et al., Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 2002, 514, 315-322.
33. Goto, T., Kim, Y. I., Funakoshi, K., Teraminami, A. et al., Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARalpha-dependent and -independent pathway. Am. J. Physiol. Endocrinol. Metab. 2011, 301, E1022-E1032.
34. Tordjman, K. M., Leingang, K. A., James, D. E., Mueckler, M. M., Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment. Proc. Natl. Acad. Sci. USA 1989, 86, 7761-7765.
35. Goto, T., Takahashi, N., Hirai, S., Kawada, T., Various terpenoids derived from herbal and dietary plants function as PPAR modulators and regulate carbohydrate and lipid metabolism. PPAR Res. 2010, 2010, 483958.
36. Yajima, H., Ikeshima, E., Shiraki, M., Kanaya, T. et al., Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. J. Biol. Chem. 2004, 279, 33456-33462.
37. Nagaoka, S., Futamura, Y., Miwa, K., Awano, T. et al., Identification of novel hypocholesterolemic peptides derived from bovine milk beta-lactoglobulin. Biochem. Biophys. Res. Commun. 2001, 281, 11-17.
38. Matoba, N., Usui, H., Fujita, H., Yoshikawa, M., A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett. 1999, 452, 181-184.
39. Kaneko, K., Iwasaki, M., Yoshikawa, M., Ohinata, K., Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut mu(1)-receptor coupled to 5-HT(1A), D(2), and GABA(B) systems. Am. J. Physiol. Gastrointest Liver Physiol. 2010, 299, G799-G805.
40. Mochida, T., Hira, T., Hara, H., The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 2010, 151, 3095-3104.
41. Martinez-Villaluenga, C., Dia, V. P., Berhow, M., Bringe, N. A. et al., Protein hydrolysates from beta-conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitro. Mol. Nutr. Food Res. 2009, 53, 1007-1018.
42. Martinez-Villaluenga, C., Rupasinghe, S. G., Schuler, M. A., Gonzalez de Mejia, E., Peptides from purified soybean beta-conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain. FEBS J. 2010, 277, 1481-1493.
43. Barrett, J. R., The science of soy: what do we really know? Environ. Health Perspect. 2006, 114, A352-A358.
44. Carroll, K. K., The role of dietary protein in hypercholesterolemia and atherosclerosis. Lipids 1978, 13, 360-365.
45. Noriega-López, L., Tovar, A. R., Gonzalez-Granillo, M., Hernández-Pando, R. et al., Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J. Biol. Chem. 2007, 282, 20657-20666.
46. Davis, J., Higginbotham, A., O'Connor, T., Moustaid-Moussa, N. et al., Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann. Nutr. Metab. 2007, 51, 42-52.
47. Frigolet, M. E., Torres, N., Uribe-Figueroa, L., Rangel, C. et al., White adipose tissue genome wide-expression profiling and adipocyte metabolic functions after soy protein consumption in rats. J. Nutr. Biochem. 2011, 22, 118-129.
48. Takahashi, Y., Ide, T., Effects of soy protein and isoflavone on hepatic fatty acid synthesis and oxidation and mRNA expression of uncoupling proteins and peroxisome proliferator-activated receptor gamma in adipose tissues of rats. J. Nutr. Biochem. 2008, 19, 682-693.
49. Nagasawa, A., Fukui, K., Kojima, M., Kishida, K. et al., Divergent effects of soy protein diet on the expression of adipocytokines. Biochem. Biophys. Res. Commun. 2003, 311, 909-914.
50. Cho, K. W., Lee, O. H., Banz, W. J., Moustaid-Moussa, N. et al., Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J. Nutr. Biochem. 2010, 21, 841-847.
51. Li, Z., Hong, K., Saltsman, P., DeShields, S. et al., Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur. J. Clin. Nutr. 2005, 59, 411-418.
52. Lee, J., Roh, K. B., Kim, S. C., Lee, J. et al., Soy peptide-induced stem cell proliferation: involvement of ERK and TGF-β1. J. Nutr. Biochem. 2012, 23, 1341-1351.
53. Prusty, D., Park, B. H., Davis, K. E., Farmer, S. R., Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 2002, 277, 46226-46232.
54. Tang, Q. Q., Otto, T. C., Lane, M. D., Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100, 44-49.
55. Bost, F., Aouadi, M., Caron, L., Even, P. et al., The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 2005, 54, 402-411.
56. Rodriguez, A., Duran, A., Selloum, M., Champy, M. F. et al., Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab. 2006, 3, 211-222.
57. Park, B. H., Qiang, L., Farmer, S. R., Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol. Cell Biol. 2004, 24, 8671-8680.
58. Kawai, M., Rosen, C. J., PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat. Rev. Endocrinol. 2010, 6, 629-636.
59. Cristancho, A. G., Lazar, M. A., Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 2011, 12, 722-734.